Acrivon Therapeutics, Inc. - COMMON STOCK (ACRV)

Historical Portfolio Holders from Q4 2022 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COMMON STOCK
Shares, excl. options Q3 2024
23M
Holdings value Q3 2024
$161M
Value change Q3 2024
-$2.68M
Grand Portfolio weight change Q3 2024
0%
Number of holders
51
Number of buys Q3 2024
22
Number of sells Q3 2024
-21
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 23M $161M -$2.68M $7.00 51
2024 Q2 23.5M $136M +$47.4M $5.80 51
2024 Q1 15.2M $109M +$3.39M $7.15 44
2023 Q4 14.9M $73.1M +$986K $4.92 40
2023 Q3 15.1M $144M -$326K $9.56 43
2023 Q2 15.1M $196M -$1.15M $12.96 40
2023 Q1 15.2M $191M +$6.82M $12.69 39
2022 Q4 15M $170M +$170M $11.52 18